文献速递头颈介入技术与安全US

超声引导下射频消融与再次手术治疗甲状腺切除术后VI区淋巴结复发对比

Ultrasound-Guided Radiofrequency Ablation versus Reoperation for Level VI Lymph Nodes Recurrence After Thyroidectomy.
PubMed 文献 · Acad Radiol · 2025-06-19

回顾性分析74例甲状腺切除术后VI区淋巴结复发患者,分别接受超声引导下射频消融(US-RFA)或再次手术。两组无复发生存率和甲状腺球蛋白水平无统计学显著差异,再次手术组总体并发症发生率显著更高,US-RFA与更少出血、更小切口、更短手术时间和住院时间相关。

要点

  • US-RFA与再次手术在VI区淋巴结复发治疗中疗效相当,无复发生存率和Tg水平无显著差异。
  • 再次手术组总体并发症发生率显著高于US-RFA组,主要和次要并发症发生率两组相当。
  • US-RFA具有出血少、切口小、手术时间短和住院时间短的微创优势。

核心结论

  • US-RFA治疗甲状腺切除术后VI区淋巴结复发的疗效与再次手术相当,且微创、并发症更少。

研究设计与样本

  • 回顾性分析,纳入2019年2月至2022年6月在福建省立医院治疗的74例甲状腺切除术后VI区淋巴结复发患者,均接受US-RFA或再次手术。

诊断标准与关键数值

  • US-RFA组37例(平均年龄48.86±15.81岁;女性25例),再次手术组37例(平均年龄49.14±15.76岁;女性25例)。
  • 两组VI区淋巴结无复发生存率和血清Tg水平差异均无统计学意义(p>0.05)。
  • 两组主要和次要并发症发生率相当(p>0.05),但再次手术组总体并发症发生率显著高于US-RFA组(p<0.05)。
  • US-RFA与更少出血、更小切口、更短手术时间和更短住院时间相关(均p<0.001)。

临床应用与阅片要点

  • 对于甲状腺切除术后VI区淋巴结复发,US-RFA可作为与再次手术疗效相当的微创选择。
  • US-RFA在减少总体并发症、出血、切口大小、手术时间和住院时间方面具有优势。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: To compare the safety and efficacy of Ultrasound-Guided Radiofrequency Ablation (US-RFA) and reoperation in the management of level VI Lymph nodes (LNs) recurrence after thyroidectomy.

METHODS: A retrospective analysis was conducted on 74 patients who underwent treatment at Fujian Provincial Hospital between February 2019 and June 2022 for level VI LNs recurrence following thyroidectomy. All patients received either US-RFA or reoperation. The volume reduction rate (VRR) of level VI LNs was evaluated before and after US-RFA. The serum thyroglobulin (Tg) levels, recurrence and complication rates of level VI LNs were recorded and compared between the two groups. Disease progression was analyzed using Kaplan-Meier curves.

RESULTS: A total of 37 patients (mean age 48.86 ± 15.81; 25 females) in the US-RFA group and 37 patients (mean age 49.14 ± 15.76; 25 females) in the reoperation group were followed up. There were no statistically significant differences in recurrence-free survival of level VI LNs or Tg levels between the two groups (p > 0.05). The incidence rates of major and minor complications were comparable between the two groups (p > 0.05), but the overall complication rate was significantly higher in the reoperation group compared to the US-RFA group (p < 0.05). Additionally, US-RFA was related to less blood loss, smaller incisions, shorter procedure times, and a reduced length of hospitalization (all p < 0.001).

CONCLUSION: US-RFA is as effective as reoperation for Level VI LNs recurrence after thyroidectomy, offering the advantages of being minimally invasive and associated with fewer complications.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Lin X, Tang L, Xie Y, et al. Ultrasound-Guided Radiofrequency Ablation versus Reoperation for Level VI Lymph Nodes Recurrence After Thyroidectomy. Acad Radiol. 2025. PMID: 40541550. doi:10.1016/j.acra.2025.05.060

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。